Perioperative Multimodal Analgesia Protocol for Supratentorial Craniotomy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorBeijing Tiantan Hospital

About this trial

Supratentorial craniotomy is one of the most common neurosurgical procedures, with severe perioperative pain. Inadequate perioperative pain relief has been associated with increased blood pressure and intracranial pressure, favoring bleeding and cerebral cerebral hypoperfusion. The ideal analgesia for neurosurgery requires complete pain relief, eliminates the side effects of opioid drugs and no influence for neurological function. Previous studies have proposed a multimodal analgesic strategy, combining analgesics and local anaesthesia, it is expected to achieve the above benefits.

Eligibility criteria

Qualifiers

Aged from 18 to 65 years

American Society of Anesthesiologists physical status I to III

Scheduled to undergo elective supratentorial tumor resection

Disqualifiers

Incision-area skin infection

A history of previous craniotomy

Allergy to study medications

A history of preoperative change in consciousness or cognitive function

Trial design

Treatments tested in this trial

  • Dexmedetomidine
  • Normal saline
  • Local analgesic techniques
  • no Local analgesic techniques

Treatment groups

2,000 Participants
are divided into 4 treatment groups

Locations

This trial has no locations

Sponsors and collaborators